4.3 Article

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Novel therapeutic options for multiple sclerosis

Francois Curtin et al.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)

Article Clinical Neurology

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria

Chris H. Polman et al.

ANNALS OF NEUROLOGY (2011)

Review Pharmacology & Pharmacy

Monoclonal Antibody Pharmacokinetics and Pharmacodynamics

W. Wang et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)

Article Neurosciences

Inhibition of multiple sclerosis-associated retrovirus as biomarker of interferon therapy

Giuseppe Mameli et al.

JOURNAL OF NEUROVIROLOGY (2008)